26 completed, 7 unknown, 6 terminated, 5 recruiting. 47 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 47 | Completed 26, Unknown 7, Terminated 6, Recruiting 5, Withdrawn 2, Not yet recruiting 1 |
| Phase 2 | 4 | Completed 4 |
Follow Tamsulosin: new trials by email Literature Review of Tamsulosin trials Research Report on Tamsulosin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic Hyperplasia Finasteride 5 mg Tablet, single dose, Tamsulosin 0.4Mg Capsule - Benign Prostatic Hyperplasia | Phase 3 | Not yet recruiting | Il-Yang Pharm. Co., Ltd. | 660 | 2026-11-09 | 2026-10-13 |
| Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms Tamsulosin Hydrochloride 0.4 mg, Solifenacin Succinate 5 mg, Mirabegron 25 mg - Ureteral Stent-Related Symptom | Phase 3 | Recruiting | Bir Hospital | 189 | 2025-08-30 | 2025-09-08 |
| Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms Terazosin, Tamsulosin - Stent Related Symptoms | Phase 3 | Recruiting | Penang Hospital, Malaysia | 150 | 2025-06-01 | 2026-07-24 |
| Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery Tamsulosin, Placebo - Postoperative Urinary Retention (POUR) | Phase 3 | Recruiting | TriHealth Inc. | 166 | 2025-02-03 | 2025-02-25 |
| Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve. Tamsulosin, Oxybutynin, Trimethoprim/sulfamethoxazole (TMP/SMZ) - Posterior Urethral Valve | Phase 3 | Recruiting | Mansoura University | 50 | 2024-11-01 | 2024-12-20 |
| Function of Tamsulosin in Older Males Undergoing Surgery With Indwelling Catheter Tamsulosin, Control Group - Postoperative Urinary Tract Infection | Phase 3 | Completed | Emory University | 87 | 2024-02-26 | 2026-04-09 |
| Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection pr Sandoz Tamsulosin, Glucose - Urinary Retention, Colorectal Surgery | Phase 3 | Recruiting | CHU de Quebec-Universite Laval | 220 | 2023-11-10 | 2026-09-10 |
| Comparative Study for Medical Therapy for Lower Ureteral Stones • The study will include 180 randomly selected patients who met inclusion criteria were randomized into four groups: silodosin 8 mg (Group A), tamsulosin 0.4 mg (Group B), silodosin 8 mg plus tadalaf - Lower Ureteral Stones | Phase 3 | Completed | Beni-Suef University | 180 | 2023-11-01 | 2024-11-27 |
| Effect of Preoperative Tamsulosin on Postoperative Urinary Retention Tamsulosin, Placebo - Postoperative Retention of Urine | Phase 3 | Completed | Endeavor Health | 179 | 2023-07-01 | 2025-10-28 |
| Silodosin vs Tamsulosin as MET Silodosin, Tamsulosin - Stone, Urinary | Phase 3 | Unknown | Princess Margaret Hospital, Hong Kong | 80 | 2022-05-31 | 2022-10-06 |
| Tamsulosin Assisted Ureteral Access Sheath Insertion Tamsulosin - Renal Stone, Retrograde Intrarenal Surgery | Phase 3 | Completed | Sengkang General Hospital | 110 | 2022-03-01 | 2026-09-30 |
| Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms Mirabegron 50 MG, Tamsulosin, Solifenacin Succinate 10 MG - Ureteral Stent, Stent Related Symptoms | Phase 3 | Unknown | Mansoura University | 240 | 2021-12-01 | 2021-11-23 |
| REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial Tamsulosin Hydrochloride, Placebos - Urinary Catheterization, Thoracic Surgery | Phase 3 | Unknown | McMaster University | 350 | 2021-07-30 | 2021-02-25 |
| Efficacy of Antihistamine Drugs as Medical Expulsive Therapy Alone or in Combination With Alpha Blockers: A Prospective Randomized Controlled Study Tamsulosin, Cetirizine, Cetirizine + Tamsulosin - Lower Ureteric Stones | Phase 3 | Completed | South Valley University | 480 | 2021-03-01 | 2024-12-31 |
| Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia Composite Steep-pulse Treatment Device, Tamsulosin Hydrochloride Capsules - Benign Prostatic Hyperplasia | Phase 2 / Phase 3 | Completed | REMD Medical Technology | 160 | 2020-08-20 | 2022-09-07 |
| Effect of Tamsulosin on PE Compared With Paroxetine Hydrochloride Tamsulosin, Paroxetine Hydrochloride, placebo - Premature Ejaculation | Phase 3 | Unknown | Assiut University | 160 | 2019-04-01 | 2019-03-19 |
| Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery Placebo oral capsule, Tamsulosin - Urinary Retention, Lower Urinary Tract Symptoms | Phase 2 / Phase 3 | Completed | University Hospitals Cleveland Medical Center | 132 | 2018-08-01 | 2021-11-08 |
| Effect of Perioperative Selective alpha1-blockers in Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones: A Randomized Controlled Trial Tamsulosin Oral Capsule, Placebo - Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones | Phase 3 | Completed | Ain Shams University | 120 | 2017-09-01 | 2020-09-21 |
| The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction Tamsulosin 0.2mg, Tadalafil 5mg, Placebo for Tamsulosin - Benign Prostatic Hyperplasia, Erectile Dysfunction | Phase 3 | Unknown | IlDong Pharmaceutical Co Ltd | 330 | 2016-03-01 | 2016-08-12 |
| Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH Tamsulosin 0.2mg + Solifenacin 5mg, Tamsulosin 0.2mg + Placebo(Solifenacin) - Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia | Phase 3 | Completed | Jeil Pharmaceutical Co., Ltd. | 780 | 2016-02-01 | 2019-08-29 |
Showing 20 of 47. Sign in to see all of them.
Prostatic Hyperplasia (19) · Lower Urinary Tract Symptoms (6) · Urinary Retention (5) · Erectile Dysfunction (2) · Kidney Calculi (2) · Ureterolithiasis (2) · Urinary Tract Infections (2) · Calculi (1) · Catheter-Related Infections (1) · Hyperplasia (1) · Male Urogenital Diseases (1) · Nephrolithiasis (1) · Pain, Postoperative (1) · Pelvic Organ Prolapse (1) · Postoperative Complications (1)
Eli Lilly and Company (3) · Astellas Pharma Europe B.V. (2) · Boehringer Ingelheim (2) · GlaxoSmithKline (2) · IlDong Pharmaceutical Co Ltd (2) · Mansoura University (2) · RECORDATI GROUP (2) · Ain Shams University (1) · Albert Einstein Healthcare Network (1) · Apsen Farmaceutica S.A. (1) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · Beni-Suef University (1) · Bir Hospital (1) · CHU de Quebec-Universite Laval (1)
United States (12) · South Korea (10) · France (6) · Germany (6) · Italy (6) · Belgium (5) · Egypt (5) · Poland (5) · United Kingdom (5) · Brazil (4) · Netherlands (4) · Austria (3) · Canada (3) · China (3) · Czechia (3)
Ahmed Elkashef (1) · Amr A Elsawy (1) · Andrew Urquhart, MD (1) · Ashraf Tarek Hafez (1) · Christopher Re Chapple, BSc MD (1) · Eric Bellissant, MD, PhD (1) · Eric Bouvard, MD (1) · Evie H Carchman, MD (1) · Graham Chapman (1)
PMID 21109344, PMID 21149761, PMID 22297243, PMID 23346990, PMID 25712312, PMID 26299520, PMID 29490509, PMID 31930360, PMID 33894146, PMID 34184246, PMID 37811598, PMID 40220053
2008 (2)